Freestone Grove Partners LP Boston Scientific Corp Transaction History
Freestone Grove Partners LP
- $8.16 Trillion
- Q4 2024
A detailed history of Freestone Grove Partners LP transactions in Boston Scientific Corp stock. As of the latest transaction made, Freestone Grove Partners LP holds 298,953 shares of BSX stock, worth $31.6 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
298,953Holding current value
$31.6 Million% of portfolio
0.33%Shares
1 transactions
Others Institutions Holding BSX
# of Institutions
1,661Shares Held
1.22BCall Options Held
8.76MPut Options Held
9.42M-
Vanguard Group Inc Valley Forge, PA133MShares$14 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY126MShares$13.4 Billion0.22% of portfolio
-
State Street Corp Boston, MA64MShares$6.76 Billion0.23% of portfolio
-
Primecap Management CO Pasadena, CA36.9MShares$3.9 Billion2.61% of portfolio
-
Wellington Management Group LLP Boston, MA36.2MShares$3.82 Billion0.61% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $151B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...